Table 1.
Signal detection for CDDP-associated mild, severe and lethal hypersensitivity reactions
Mild | Severe | Lethal | |
---|---|---|---|
43,288 | 18,225 | 2,397 | |
No.of AERs | 38 | 29 | 5 |
PRR (kai2) | 0.436 (27.256) | 0.790 (1.412) | 1.036 (0.022) |
ROR (95% two-sided CI) | 0.435 (0.317, 0.553) | 0.790 (0.549, 1.031) | 1.036 (0.431, 1.641) |
IC (95% two-sided CI) | -1.195 (-1.651, -0.739) | -0.353 (-0.875, 0.169) | -0.081 (-1.287, 1.125) |
EBGM (95% one-sided CI) | 0.441 (0.337) | 0.781 (0.574) | 0.907 (0.455) |
Total number of adverse event reports (AERs) accompanied with CDDP administration was 44,321. Reports of mild, severe and lethal hypersensitivity reactions numbered 43,288, 18,225 and 2,397, respectively. PRR: the proportional reporting ratio 33, ROR: the reporting odds ratio 34, IC: the information component 35, EBGM: the empirical Bayes geometric mean 36. There was no signal for CDDP-associated mild, severe and lethal hypersensitivity reactions (see “Methods” for the criteria of detection).